SMN2 and proximal spinal muscular atrophy: In order to explore this, we first developed and validated an in utero transplacental therapeutic intervention using risdiplam to investigate whether SMN protein levels could be restored in SMA Taiwanese mouse embryos following treatment of the pregnant dam, with consequential impacts on the prenatal primary cilia phenotypes.